Frankfurt
03.09.26 | 08:22
6,350 Euro
+5,83 % +0,350
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 6,350 | 6,600 | 21:59 | |
| 6,450 | 6,550 | 21:59 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| EXAGEN Aktie jetzt für 0€ handeln | |||||
| 11.08. | Exagen auf Wachstumskonferenz von Canaccord Genuity: Turnaround gewinnt an Fahrt | 5 | Investing.com Deutsch | ||
| 04.08. | Exagen targets $72M-$75M 2026 revenue outlook as profitability nears breakeven | 4 | Seeking Alpha | ||
| 04.08. | Exagen Q2 2026 slides: record revenue, stock surges 30% on results | 2 | Investing.com | ||
| 04.08. | Exagen Q2 2026 slides: record revenue, stock surges 36% | 2 | Investing.com | ||
| 04.08. | EXAGEN INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 04.08. | Exagen GAAP EPS of -$0.13 beats by $0.06, revenue of $19.94M beats by $2.07M | 2 | Seeking Alpha | ||
| 04.08. | Exagen Inc. Reports Second Quarter 2026 Financial Results | 509 | GlobeNewswire (Europe) | Achieved record total revenue, test volume and trailing twelve-month ASP Reduced net loss by nearly 30% and narrowed adjusted EBITDA loss to $0.1 million Increased full-year revenue guidance to... ► Artikel lesen | |
| 04.08. | EXAGEN INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 21.07. | Exagen Inc.: Exagen to Announce Second Quarter Financial Results on August 4, 2026 | 1 | GlobeNewswire (USA) | ||
| 09.06. | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.06. | Exagen Inc.: Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus | 1 | GlobeNewswire (USA) | ||
| 12.05. | BTIG senkt Kursziel für Exagen auf 8 US-Dollar, bestätigt aber 'Buy'-Rating | 6 | Investing.com Deutsch | ||
| 12.05. | Exagen stock price target lowered to $8 by BTIG on valuation | 1 | Investing.com | ||
| 12.05. | Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time | 1 | Seeking Alpha | ||
| 11.05. | Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates | 1 | Zacks | ||
| 11.05. | Exagen: EPS übertrifft Schätzungen um 0,05 $ - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| 11.05. | EXAGEN INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.05. | Exagen beats top-line and bottom-line estimates; reaffirms FY26 outlook | 1 | Seeking Alpha | ||
| 11.05. | Exagen Inc. Reports First Quarter 2026 Results | 280 | GlobeNewswire (Europe) | CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026... ► Artikel lesen | |
| 11.05. | EXAGEN INC. - 8-K, Current Report | - | SEC Filings |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 23,940 | -3,23 % | Reasons to Retain Hims & Hers Stock in Your Portfolio for Now | ||
| CERENOME | 2,410 | +0,42 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| HENRY SCHEIN | 77,50 | -1,27 % | Growth Trajectory and Attractive Valuations Support Henry Schein's (HSIC) Bullish Thesis | ||
| CO-DIAGNOSTICS | 1,160 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| AMBU | 9,405 | -1,67 % | Ambu A/S: Interim Report For Q3 | 25.8.2026 18:01:05 CEST | Ambu A/S |
Interim report (Q1 and Q3)
In Q3 2025/26, Ambu delivered organic revenue growth of 10.3%, driven by strong performance in Endoscopy Solutions growing 16.0% organically.... ► Artikel lesen | |
| CYTOSORBENTS | 0,298 | -10,24 % | Cytosorbents Corp: CytoSorbents Announces Reverse Stock Split | Reverse Stock Split Previously Approved by Shareholders; Intended to Support Compliance with Nasdaq's $1.00 Minimum Bid Price Requirement
Expected to Become Effective... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,740 | +0,54 % | Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes | ||
| FULGENT GENETICS | 17,300 | 0,00 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| PERIMETER MEDICAL IMAGING AI | 0,148 | +6,47 % | Perimeter Medical Imaging AI Inc.: Perimeter Announces Preliminary Second Quarter 2026 Financial Results | Results characterized by continued strong commercial momentum and improved operating performance
Conference call/webcast today at 5:00 pm ET
TORONTO and DALLAS... ► Artikel lesen | |
| ICON | 138,25 | +0,14 % | ICON plc: ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability | ICON plc (NASDAQ: ICLR) ("ICON"), a world-leading clinical research organisation, today releases its ICON Cares 2025 Report which outlines how the company is delivering on its environmental, social... ► Artikel lesen | |
| IMAGIN MEDICAL | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2026.ISIN NameCA2985962067 EUREKA... ► Artikel lesen | |
| MEMPHASYS | 0,002 | 0,00 % | MEMPHASYS LIMITED: Felix Registration Achieved in Turkey, Sales Commence | ||
| ESTABLISHMENT LABS | 64,38 | +9,42 % | Baron Discovery Fund's Strategic Trim of Establishment Labs Holdings Inc (ESTA) Locks Gains | ||
| EMBECTA | 4,901 | -0,12 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ELECTROCORE | 7,950 | +4,61 % | electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes | Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness... ► Artikel lesen |
Das Unternehmen EXAGEN INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 6,350 Euro und damit +5,83 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXAGEN INC finden Sie auf Wallstreet Online.